Admetsys (@admetsys) 's Twitter Profile
Admetsys

@admetsys

Admetsys has developed the first fully-automated glucose control system (artificial pancreas) specifically for the needs of hospital & surgical care. 〽️

ID: 2862583774

linkhttp://www.admetsys.com calendar_today05-11-2014 14:19:25

967 Tweet

716 Followers

1,1K Following

Mohammed Bin Rashid Innovation Fund (@mbrifund) 's Twitter Profile Photo

The MBRIF has two distinct offerings for startups: 1. Accelerator 2. Government backed guarantees. Admetsys, a Boston based medical startup, was a member of our accelerator’s first cohort. This facilitated their growth in the UAE & other countries outside of their home turf. 👇

The MBRIF has two distinct offerings for startups: 1. Accelerator 2. Government backed guarantees. Admetsys, a Boston based medical startup, was a member of our accelerator’s first cohort. This facilitated their growth in the UAE & other countries outside of their home turf. 
👇
Mohammed Bin Rashid Innovation Fund (@mbrifund) 's Twitter Profile Photo

Their accelerator journey enabled them to kick-off qualification discussions for the Guarantee Scheme, which provides financial solutions for innovative companies. Get in touch and learn more here: mbrif.ae #MBRIF

Their accelerator journey enabled them to kick-off qualification discussions for the Guarantee Scheme, which provides financial solutions for innovative companies. Get in touch and learn more here: mbrif.ae
#MBRIF
Admetsys (@admetsys) 's Twitter Profile Photo

In these difficult times of #COVID19, Admetsys is 1 step closer to launching scalable, automated & remotely viewable real-time #diagnostics + #glycemiccontrol-perfect for #hospital isolation rooms. Our CE technical file review is complete. #ArtificialPancreas #Automation #AI #T1D

In these difficult times of #COVID19, Admetsys is 1 step closer to launching scalable, automated & remotely viewable real-time #diagnostics + #glycemiccontrol-perfect for #hospital isolation rooms. Our CE technical file review is complete. #ArtificialPancreas #Automation #AI #T1D
Admetsys (@admetsys) 's Twitter Profile Photo

See Admetsys and other great innovators present online tomorrow as part of the MedStartr Retired - Health 2.0 Europe #Health20NYC #WarOnCOVID Challenge as we work towards mitigating #COVID19 through information-driven scalable diagnostics and automated care. Join via meetup.com/health20nyc/ev…

See <a href="/Admetsys/">Admetsys</a> and other great innovators present online tomorrow as part of the <a href="/MedStartr/">MedStartr</a> <a href="/Health2eu/">Retired - Health 2.0 Europe</a> #Health20NYC #WarOnCOVID Challenge as we work towards mitigating #COVID19 through information-driven scalable diagnostics and automated care. Join via meetup.com/health20nyc/ev…
Health Finance Institute (@healthfininst) 's Twitter Profile Photo

We analyzed CDC prevalence of #ChronicDisease and #COVID19 data: those w/ #diabetes infected w/ #COVID19 are ~7 times as likely to need the ICU vs. those w/o diabetes. #NCDs prevention saves health systems & lives: World Health Organization (WHO) Eric Feigl-Ding @andreafeigl1 Sandro Galea NCD Alliance

We analyzed <a href="/CDCgov/">CDC</a> prevalence of #ChronicDisease and #COVID19 data: those w/ #diabetes infected w/ #COVID19 are ~7 times as likely to need the ICU vs. those w/o diabetes. 
#NCDs prevention saves health systems &amp; lives: 
<a href="/WHO/">World Health Organization (WHO)</a> <a href="/DrEricDing/">Eric Feigl-Ding</a> @andreafeigl1 <a href="/sandrogalea/">Sandro Galea</a> <a href="/ncdalliance/">NCD Alliance</a>
Admetsys (@admetsys) 's Twitter Profile Photo

Thank you to MedStartr Retired - Health 2.0 Europe #Health20NYC for allowing us to join the #WarOnCOVID Challenge during these unique times. We look forward to working with you and other innovators as we jointly work towards mitigating #COVID19 and supporting medical staff and patients.

Admetsys (@admetsys) 's Twitter Profile Photo

Watch Admetsys present on creating value for patients and healthcare at #efpPhilly @eyeforpharma Philadelphia Virtual, the largest commercial pharma conference, on April 14th at 5 PM ET. Register at eyeforpharma.com/philadelphia/c… #ArtificialPancreas #T1D

Watch <a href="/Admetsys/">Admetsys</a> present on creating value for patients and healthcare at #efpPhilly @eyeforpharma Philadelphia Virtual, the largest commercial pharma conference, on April 14th at 5 PM ET.  Register at eyeforpharma.com/philadelphia/c… #ArtificialPancreas #T1D
MedStartr (@medstartr) 's Twitter Profile Photo

Come watch the companies that are changing the healthcare landscape and addressing #COVID19 head on! #WarOnCovid @helpsyhealth Face2Face Health Elemeno Health Emanate Wireless PhenoMx, Inc. HealthMode Admetsys, and rivertown bioscience. Plus 2 wildcards! bit.ly/3csj17M

MedStartr (@medstartr) 's Twitter Profile Photo

All the companies did amazing last night. Thank you to everyone who help made this possible. The Finale Results on the war on COVID Competition 1 st place Lincoln advantage technologies 2nd place Admetsys And a tie for crowd favorite PhenoMx, Inc. and Elemeno Health

Admetsys (@admetsys) 's Twitter Profile Photo

Poorly-controlled glucoses in hospitalized #COVID19 patients increases death rates significantly. "These findings provide clinical evidence correlating improved glycemic control with better outcomes in patients with COVID-19 and pre-existing T2D." pubmed.ncbi.nlm.nih.gov/32369736/

Poorly-controlled glucoses in hospitalized #COVID19 patients increases death rates significantly. "These findings provide clinical evidence correlating improved glycemic control with better outcomes in patients with COVID-19 and pre-existing T2D." pubmed.ncbi.nlm.nih.gov/32369736/
Admetsys (@admetsys) 's Twitter Profile Photo

Admetsys Secures CE Mark Approval for PrecisionOne™ Automated Glycemic Control and Continuous Diagnostics System 👏👏👏👏 prnewswire.com/news-releases/…

Admetsys Secures CE Mark Approval for PrecisionOne™ Automated Glycemic Control and Continuous Diagnostics System 👏👏👏👏 prnewswire.com/news-releases/…
Admetsys (@admetsys) 's Twitter Profile Photo

Admetsys is honored to be nominated to the Mass Technology Leadership Council Tech Top 50 program for the recent CE Mark approval of the novel PrecisionOne™ Automated Glycemic Control and Continuous Diagnostics System. #ThankYou finance.yahoo.com/news/admetsys-…

Admetsys is honored to be nominated to the <a href="/MassTLC/">Mass Technology Leadership Council</a> Tech Top 50 program for the recent CE Mark approval of the novel PrecisionOne™ Automated Glycemic Control and Continuous Diagnostics System. #ThankYou finance.yahoo.com/news/admetsys-…
Mass Technology Leadership Council (@masstlc) 's Twitter Profile Photo

#TechTop50Honoree Congrats to .Admetsys for their PrecisionOne system that functions as a metabolic autopilot, providing automated gluclose regulation and real-time blood chemistry analysis for diabetes patients👏 #Innovation

#TechTop50Honoree Congrats to .<a href="/admetsys/">Admetsys</a> for their PrecisionOne system that functions as a metabolic autopilot, providing automated gluclose regulation and real-time blood chemistry analysis for diabetes patients👏  #Innovation
Admetsys (@admetsys) 's Twitter Profile Photo

Join Admetsys at 14:30pm GMT on 2nd December 2020 online at GIANT 2020 @gianthealthevnt to learn more about Admetsys' PrecisionOne™ Automated Glycemic Control and Continuous Diagnostics System for Hospital and Surgical Care. prnewswire.com/news-releases/…

Join Admetsys at 14:30pm GMT on 2nd December 2020 online at GIANT 2020 @gianthealthevnt to learn more about Admetsys' PrecisionOne™ Automated Glycemic Control and Continuous Diagnostics System for Hospital and Surgical Care. prnewswire.com/news-releases/…